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Objective: Cerebral inflammatory reaction is discussed as a contributor to adverse cerebral outcome after cardiac
surgery with cardiopulmonary bypass. This study was designed to determine the effect of cardiopulmonary by-
pass on both cerebral expression of tumor necrosis factor a and neurocognitive outcome in rats.
Methods:With institutional review board approval, 50 rats were randomly assigned to one of 3 groups: rats of the
cardiopulmonary bypass group were subjected to 75 minutes of normothermic cardiopulmonary bypass. Sham-
operated animals underwent identical preparation but were not connected to cardiopulmonary bypass, whereas
rats of the control group were neither anesthetized nor cannulated. Ten rats per group survived 4 hours after car-
diopulmonary bypass or the sham operation for immediate postoperative determination of tumor necrosis factor
a–expressing cells (immunohistochemistry) and cerebral tumor necrosis factor a mRNA levels (polymerase
chain reaction). The remaining animals survived 10 days for neurocognitive assessment by using the modified
hole-board test and for analysis of cerebral tumor necrosis factor a activation in the late postoperative period.
Results: Expression of tumor necrosis factor a mRNA was increased 4 hours after cardiopulmonary bypass and
the sham operation, with higher expression in the cardiopulmonary bypass group (c2 [2]¼ 25.08, P<.001). Both
experimental groups demonstrated larger numbers of tumor necrosis factor a–positive cells in the early and late
postoperative periods (F [1] ¼ 13.08, P  .001) and an impaired neurocognitive performance on the first post-
operative days compared with that seen in the control group (F [2, 24] ¼ 4.26, P ¼ .02).
Conclusions: Cerebral tumor necrosis factor a activation in both experimental groups during the early postop-
erative period was accompanied by transient neurocognitive impairment. Therefore cardiopulmonary bypass
alone demonstrated no effect on cerebral inflammation and neurocognitive outcome.Although considerable advancements in surgical and anes-
thetic techniques have improved overall morbidity and
mortality in patients undergoing cardiac surgery with cardio-
pulmonary bypass (CPB), neurologic and neurocognitive
dysfunction remain as common and long-lasting complica-
tions.1 The cause of these adverse outcomes is likely multi-
factorial, including mainly the effects of microembolization
and global cerebral hypoperfusion next to systemic inflam-
mation.2 The inflammatory cascade is specifically activated
during CPB through several pathways: the contact activation
by the foreign surface of the circuit, surgical trauma, and the
effect of ischemia–reperfusion injury and endotoxemia.3,4
Human studies examining the effect of systemic inflamma-
tory reaction on cerebral outcome after CPB have revealed
conflicting results.3,5,6 The advantage of an animal model
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and consequently its effect on neurocognitive outcome. An
important step forward was the study by Hindman and
colleagues7 demonstrating a link between systemic interleu-
kin 6 and cerebral cyclooxygenase 2 mRNA expression, but
the time course of cerebral inflammation and the association
with neurocognitive outcome after CPB have not been stud-
ied thus far.
Therefore this study was performed to investigate the
effect of CPB on (1) cerebral expression of tumor necrosis
factor (TNF) a and (2) neurocognitive outcome. Further-
more, as secondary end points, we investigated levels of
cerebral TNF-a mRNA and behavioral outcome because
these parameters might influence the primary end points.
MATERIALS AND METHODS
Study Design
All animals were treated in compliance with the ‘‘Principles of labora-
tory animal care’’ formulated for the National Society for Medical Research
and the ‘‘Guide for the care and use of laboratory animals’’ prepared by the
National Academy of Sciences (National Institutes of Health publication no.
86-23, revised 1985). Experimental protocols were approved by the
institutional animal care committee (Regierung von Oberbayern, Munich,
Germany).
Rats were randomly assigned to one of 3 groups: rats in the CPB group
were subjected to 75 minutes of normothermic CPB (n ¼ 20), whereas rats
in the sham-operated group were exposed to the same surgical preparationrgery c October 2009
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MAP ¼ mean arterial pressure
and anesthesia but not connected to CPB (n¼ 20). Rats in the naive control
group were transferred to the laboratory to mimic the stress of transport and
isolation from the familiar group but were neither anesthetized nor surgi-
cally prepared (n ¼ 10). Ten rats of the CPB and sham-operated groups
were assigned to short-term survival (4 hours of recovery), allowing for
the determination of cerebral TNF-a mRNA levels and the amount of
TNF-a–expressing hippocampal neurons and astrocytes. All other animals
were allowed to survive long-term to assess postoperative neurocognitive
performance and behavior by using the modified hole-board test next to
the determination of cerebral TNF-a levels at postoperative day 10
(Figure 1).
Surgical Preparation and CPB
Nonfasted male Sprague–Dawley rats from Charles River Laboratories
(Sulzfeld, Germany; 375  36 g, 10 weeks old) were anesthetized with
3% isoflurane in air and intubated. Ventilation was adjusted to maintain
a PaCO2 of 35 to 45 mm Hg, and anesthesia was maintained with 2.0% to
2.5% isoflurane and repetitive boluses of fentanyl (5 mg). Subsequently,
all rats of the CPB and sham-operated groups were cannulated as previously
reported by using aseptic techniques.8 Briefly, the tail artery was cannulated
for aortic inflow, the right external jugular vein for venous return, and the
right superficial caudal epigastric artery for monitoring of mean arterial
pressure (MAP). After cannulation of the tail artery, 150 IU heparin was ad-
ministered. Pericranial temperature was monitored and controlled to 37.5C
(HYP-1; Newport, Santa Ana, Calif) by using a heating blanket and convec-
tive forced-air heating system. Serum glucose concentration was controlled
at greater than 80 mg/dL, administering respective amounts of glucose 50%
as required. Arterial blood gas measurements were performed with a blood
gas analyzer (Rapidlab 860; Bayer Vital GmbH, Fernwald, Germany).
The CPB circuit consisted of a venous reservoir, peristaltic pump (Mas-
terflex; Cole-Parmer Instrument Co, Vernon Hills, Ill), custom-designed
membrane oxygenator, inline flow probe (2N806 probe and T208 flowme-
ter; Transonics Systems, Inc, Ithaca, NY), and arterial inflow cannula. The
rat oxygenator is built of 2 Plexiglas shells (12.8 cm 3 12.8 cm 3 2.7 cm)
carrying the diffusion membrane and consisting 3 layers of polypropylene
hollow-fiber mats (Jostra AG, Hirrlingen, Germany) glued together in
a crosswise fashion to improve oxygenation. The provided gas exchange
area is 558 cm2, and the prime volume of the oxygenator is 4 mL. An inte-
grated water bath allows heating the circuit and helps avoid a decrease in the
body temperature of the rat throughout extracorporal circulation. The com-
plete CPB circuit (10 mL) was primed with 8 mL of whole blood obtained
from 1 heparinized (150 IU/rat) donor rat, 2 mL of 6% hetastarch, and 100
IU of heparin.
After preparation, rats of the CPB groups were subjected to 75minutes of
normothermic, nonpulsatile CPB with flow rates of 160 to 180 mL $min1 $
kg1. During CPB, ventilation of the lungs was terminated. Anesthesia was
maintained with 0.8% to 1.2% isoflurane administered through the oxygen-
ator, subsequent doses of 5 mg of fentanyl as required, and 1.6 mg/h cisatra-
curium. Sham-operated animals were exposed to the same anesthetic
conditions for 75 minutes but not connected to the CPB circuit. After 75
minutes, animals in the CPB group were weaned fromCPBwithout any ino-
tropic support, and all animals were decannulated. The heparin anticoagula-
tion was allowed to dissipate spontaneously without supplemental
administration of protamine.
After decannulation, rats assigned to short–term recovery remained anes-
thetized, intubated, and ventilated for 4 hours after cessation of CPB. After
obtaining the final set of hemodynamic measurements, the isoflurane con-The Journal of Thoracic and Cacentration was increased to 5%, and the brains were removed and frozen
in tissue-freezing medium (Leica Instruments GmbH, Nussloch, Germany)
with methylbutane and stored at80C for further analyses. Rats assigned to
survive for 10 days (long-term survival) remained anesthetized with 1.5%
to 2% isoflurane (without additional fentanyl or cisatracurium) and were in-
tubated and ventilated for 2 hours.When animals resumed spontaneous ven-
tilation, the tracheas were extubated. The animals were allowed to recover in
an oxygen-enriched environment for 2 to 4 hours with free access to water
and food. Thereafter, they were returned to their hole-board cages and
housed in familiar groups. Rats in the untreated control group stayed in
the laboratory with free access to water and food for the identical period
to mimic hospitalization.
Neurocognitive Testing
Cognitive and behavioral parameters were assessed with the modified
hole-board test by a dedicated investigator blinded to treatment. Rats
were housed under standard laboratory conditions (12 hours of light/12
hours of dark, lights on at 12:30 AM, 22C, and 60% humidity, with free ac-
cess to water and standard rat chow) 3 weeks before the experiments to ac-
climate to the changed day/night rhythm. Nine days before neurocognitive
testing, animals were housed in the modified hole-board environment for
habituation. Subsequently, rats learned the test procedure during 10 consec-
utive days (training phase). The next day, the animals underwent surgical
preparation with or without CPB or served as control animals, followed
by a postoperative test period of 10 days.
The modified hole-board test was performed according to an established
protocol.9,10 Briefly, the rats lived in an area divided into a home cage (803
603 50 cm) and a test arena (403 603 50 cm), with the hole board (203
40 cm) placed in the middle of the arena. Fifteen holes covered by lids were
staggered on the board. After opening, coil springs force the lids back to
their original position. Three holes baited with puffed rice were marked
with white tape. All holes were flavored with black currant aroma to cover
the odor of the puffed rice. Animals were tested with the modified hole-
board test for 3 trials daily. The sequence of marked holes was randomly
changed daily.
Three cognitive parameters were evaluated: (1) deficit in overall cogni-
tive performance was assumed if the time needed to complete 1 trial was
extended compared with that among untreated control animals; (2) deficit
within the visuospatial long-term memory was assumed if rats visited non-
baited holes or did not visit baited holes, which was referred to as wrong
choice; and (3) deficit within the visuospatial short-term memory was as-
sumed if rats revisited a baited hole, which was referred to as repeated
choice. Additionally, aspects of behavior, such as motivation, anxiety,
and exploration, were assessed.10
After completion of the neurocognitive testing on postoperative day 10,
animals were anesthetized with 5% isoflurane, and the brains were removed
and frozen in tissue-freezing medium (Leica Instruments GmbH) and stored
at80C for further analyses.
Immunohistochemistry and Reverse Transcription–
Polymerase Chain Reaction
Frozen brains were cut into 10-mm slices at bregma3.3 mm by using
a cryotome (Microtom-Kryostat, HM 500 QM; Microtome, Walldorf, Ger-
many). Adjacent slices were subjected to standard histology and immuno-
histochemistry, and the remaining tissue was used to perform reverse
transcription–polymerase chain reaction.
By using immunohistochemical techniques, frozen sections were double
stained for TNF-a (polyclonal rabbit anti-rat TNF-a; Acris Antibodies
GmbH, Herford, Germany) and NeuN (Mouse Anti-Neuronal Nuclei
Monoclonal Antibody; Chemicon International, Temecula, Calif) or glial fi-
brillary acidic protein (MouseMonoclonal Anti–Glial Fibrillary Acidic Pro-
tein; Chemicon International), respectively. TNF-awas labeled dark brown
by using a biotinylated secondary antibody, peroxidase, and diaminobenzi-
dine. Neurons or astrocytes were marked bright red by using an alkalinerdiovascular Surgery c Volume 138, Number 4 1003
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phatase substrate kit (Vector Laboratories, Burlingame, Calif). The number
of TNF-a–positive cells (neurons and astrocytes) was counted in the hippo-
campus by using light microscopy (440-fold magnification).
Total RNAwas extracted with the RneasyMini Kit (Qiagen, Inc, Hilden,
Germany), followed by reverse transcription of RNA (4 mg) to cDNA with
random hexamers. By using rat primers for TNF-a and b-actin, cDNA was
coamplified (28 cycles of 94C for 1 minute, 50C for 1 minute, and 72C
for 1.5 minutes for TNF-a and 35 cycles of 94C for 30 seconds, 55C for
30 seconds, and 72C for 1 minute for b-actin). Specific rat primers were as
follows: TNF-a, sense primer CTCAAAACTCGAGTGACAAGC and an-
tisense primer CCG TGATGTCTAAGTACTTGG [NM_012675]; b-actin,
sense primer GTGGGGCGCCCCAGGCACCA and antisense primer
CTCCTTAATGTCACGCACGATTTC [BT019932]. The polymerase
chain reaction products were subjected to electrophoresis in 1.8% agarose,
stained with ethidium bromide, and photographed. The predicted lengths of
amplification products for TNF-a and b-actin were 419 and 548 bp. Results
are presented as ratios of band intensities of TNF-a MRNA to b-actin
mRNA (Quantity One Quantification software 4.1; Bio-Rad Laboratories,
Hercules, Calif).
For standard histology, slices were stained with hematoxylin and eosin.
Five high-magnification fields (440-fold) in each of 4 brain regions (stria-
tum, motorcortex, cingulate cortex, and hippocampus) were viewed by an
investigator blinded to group assignment to assess neuronal damage.
short-term (n=10): 4 hours after sham-
operation: PCR, IHC, HE
long-term (n=10): 10 days after sham-
operation: mHBT, IHC, HE
short-term (n=10): 4 hours after CPB:
PCR, IHC, HE
long-term (n=10): 10 days after CPB:
mHBT, IHC, HE
Sham (n=20)
CPB (n=20)
Control (n=10) untreated: mHBT, PCR, IHC, HE
3 Groups
(n=50)
Experimental Design
FIGURE 1. Diagram of the experimental design. Three groups were stud-
ied: the cardiopulmonary bypass (CPB) group, the sham-operated group,
and the control group. Short-term groups survived 4 hours, whereas long-
term groups survived 10 days. End points were as follows: polymerase chain
reaction (PCR), immunohistochemistry (IHC), hematoxylin and eosin stain-
ing (HE), and, in the long-term groups, results of the modified hole-board
test (mHBT).1004 The Journal of Thoracic and Cardiovascular SuStatistical Analysis
Physiologic parameters (MAP, hemoglobin concentration, PaCO2, and
PaO2) and cognitive and behavioral values were analyzed by using general
linear models with the between-group factor preparation (CPB vs sham vs
control), the within-group factor time, and their interaction term (time 3
preparation). Effects of time levels were analyzed quadratically (time2)
for physiologic, cognitive, and behavioral values, focusing on biphasic
changes of these variables during the respective observation time (operation
minutes and preoperative or postoperative days, respectively). Values were
analyzed post hoc by using factorial analyses of variance, followed by Bon-
ferroni t tests at each time point. Cerebral TNF-amRNA expression was an-
alyzed by using nonparametric analysis of variance (Kruskal–Wallis-Test)
with post hoc (given that P< .05) Mann–Whitney U tests (P< .05). Glial
and neuronal TNF-a protein expression was analyzed by using a 1-way
analysis of variance. Where analyses of variance were significant, post
hoc comparisons were performed with Tamhane’s test of significance.
RESULTS
Four rats of the CPB group died of technical problems
(cannulation problems or insufficient venous return) and
were replaced to keep the sample size equal.
Rats subjected to CPB demonstrated lower MAP (F [1,
36] ¼ 16.87, P  .001), lower hemoglobin concentrations
(F [1, 35] ¼ 5.62, P ¼ .023), and higher PaO2 values during
CPB (F [1, 36]¼ 28.18, P .001) than rats of the sham-op-
erated groups, most likely because of the nature of CPB
(Table 1).
Immunohistochemical double staining demonstrated
a larger number of TNF-a–positive neurons (CPB/long,
17.3  5.6; CPB/short, 11.7  2.3; sham/long, 16.5 
7.4; sham/short, 12.2  2.2) and astrocytes (CPB/long,
15.5  3.6; CPB/short, 12.0  3.2; sham/long, 17.1 
6.1; sham/short, 11.7  3.6) 4 hours (short) or 10 days
(long) after CPB and the sham operation compared with con-
trol animals (neurons, 2.8 1.8; astrocytes, 0.9 0.9), with
no difference between the CPB and sham-operated groups
(P  .001 and for TNF-a–positive astrocytes: F [4] ¼
25.76, P  .001; Figure 2).
Cerebral expression of TNF-a mRNA was increased 4
hours after CPB (ratio of TNF-a to b-actin mRNA, 0.089
 0.03) and the sham operation (ratio of TNF-a to b-actin
mRNA, 0.080  0.02), with higher levels in rats subjected
to CPB (c2 [2] ¼ 25.08, P< .001), whereas no cerebralTABLE 1. Physiologic data during the operative procedure in the 2 experimental groups
Preparation Pre-CPB 45 min CPB 75 min CPB 2 h post-CPB
Mean arterial pressure (mm Hg) Sham 79.4  1.4 75.0  1.4* 70.5  1.7* 74.4  1.7
CPB 81.4  1.3 66.0  2.8 63.4  2.2 73.6  1.4
Hemoglobin concentration (mg/dL) Sham 14.0  0.2 13.3  0.3* 12.5  0.2 11.7  0.3*
CPB 14.3  0.2 12.1  0.2 11.9  0.2 10.8  0.3
PaCO2 (mm Hg) Sham 38.3  1.2 38.6  0.9 38.6  0.9 37.5  0.7
CPB 40.2  0.8 42.2  1.3 38.3  0.6 35.7  1.0
PaO2 (mm Hg) Sham 182  9 191  7* 195  12* 197  8
CPB 165  6 274  18 289  17 178  12
Variables were obtained before cardiopulmonary bypass (Pre-CPB), at 45 minutes of cardiopulmonary bypass (45 min CPB), at 75 minutes of cardiopulmonary bypass (75 min
CPB), and 2 hours after cardiopulmonary bypass (2 h post-CPB) or to equivalent times in the sham-operated groups (Sham). Values are presented as means standard errors of the
mean. *P< .05 versus cardiopulmonary bypass.rgery c October 2009
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(ratio of TNF-a to b-actin mRNA, 0.0  0.0) and in all an-
imals on postoperative day 10 (Figure 3).
Histologic assessment revealed no significant neuronal
cell damage in any of the groups 4 hours after CPB or the
sham operation or 10 days postoperatively.
Overall cognitive performance was impaired during the
first 4 postoperative days after CPB and the sham operation
compared with that seen in native control rats without any
difference between the CPB and sham-operated groups.
This transient dysfunction was not accompanied by impaired
long-term or short-term memory (for the parameter time
trial: F [2, 24] ¼ 4.26, P ¼ .02; Figure 4). No differences
in behavior were detected during the observation period.
DISCUSSION
The current study demonstrates that CPB does not aggra-
vate cerebral TNF-a expression and does not cause longer-
lasting neurocognitive impairment when compared with
that seen in sham-operated rats.
In the past, several animal models of cerebral ischemia
have provided important insights into the mechanisms of in-
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FIGURE 2. Immunohistochemistry of coronal brain sections 4 hours and
10 days after cardiopulmonary bypass (CPB) and the sham operation
(Sham). The number of tumor necrosis factor a (TNF-a)–positive neurons
(A) and astrocytes (B) in the hippocampus is increased in all 4 groups com-
pared with that seen in untreated control animals (*P<.05 vs untreated con-
trol group). The dashed linemarks the upper 95% confidence interval of the
untreated control animals.The Journal of Thoracic and Caflammatory response in the brain after cerebral injury with
respect to inflammatory gene expression, inflammatory pro-
tein synthesis, and regional distribution of neurons express-
ing cytokines, particularly the proinflammatory cytokine
TNF-a.11,12 Experimentally, TNF-a has been shown to en-
hance the permeability of the blood–brain barrier; to induce
expression of endothelial adhesion molecules, leading to
further release of inflammatory mediators; and to be
involved in thrombogenic and vascular changes after brain
injury.13,14 Clinically, TNF-a levels have been shown to
increase in response to cardiac surgery with CPB.4 Therefore
we selected TNF-a as an inflammatory marker in the current
study to investigate the effect of CPB on cerebral inflamma-
tion in rats. Surprisingly, cerebral expression of TNF-a pro-
tein in neurons and astrocytes of the hippocampus was
comparable between the CPB and the sham-operated
groups, supposing no effect of CPB alone without major sur-
gical intervention in young and healthy rats undergoing
cerebral inflammation. Not only was the expression of the
protein investigated but also the gene expression as levels
of mRNA to perform a comprehensive analysis of TNF-
a as an inflammatory marker. These levels were higher in
both experimental groups when compared with those in
the control group, with a significant, although minor,
increase in the CPB group (Figure 3). One can only specu-
late whether compensatory anti-inflammatory parameters
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FIGURE 3. Tumor necrosis factor a (TNF-a) mRNA expression in the
brain 4 hours after cardiopulmonary bypass (CPB) and the sham operation
compared with that seen in control animals. TNF-a mRNA/b-actin mRNA
ratios were increased after both CPB and the sham operation, with higher
expression in the CPB group. *P< .05 vs untreated control animals; xP
< .05 versus the sham group.rdiovascular Surgery c Volume 138, Number 4 1005
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FIGURE 4. Neurocognitive function of rats at various times before and af-
ter cardiopulmonary bypass (CPB) and the sham operation. Overall cogni-
tive performance (time needed to complete the test; A) was impaired on the
first 4 postoperative days after CPB and the sham operation (P< .05) but
improved over time and reached baseline values on postoperative day 6
(P< .05). Visuospatial long-term memory (number of wrong choices; B)
was comparable among groups (P> .05). Visuospatial short-term memory
(number of repeated choices; C) was comparable among groups (P> .05).
OP, Operation.1006 The Journal of Thoracic and Cardiovascular Sumight have prevented the successful translation of TNF-
a mRNA to protein in rats of the CPB group.15 However,
TNF-a protein rather than TNF-a mRNA has been chosen
as a major end point in this study because the protein and
not the gene influences the subsequent inflammatory cas-
cade.
Of note, numbers of TNF-a–expressing neurons and as-
trocytes are still increased in the hippocampus 10 days after
CPB and the sham operation when compared with those
seen in untreated control animals. Previous experimental
studies have demonstrated TNF-a expression in the brain
peaking between 12 and 36 hours after cerebral ischemia,
with an attenuated response on postoperative day 10,16,17
whereas the microglial response peaked between 4 and 7
days after cerebral injury.18 Relating to the results of the
current study, we speculate that the early postoperative
TNF-a release at 4 hours reflects the onset of the inflamma-
tory response only. TNF-a–expressing cells detected in the
late postoperative period could then represent the remnants
of this inflammatory reaction, which is substantiated by
the absence of TNF-a mRNA 10 days after CPB and the
sham operation. Both positive and negative controls were in-
cluded in the reverse transcription–polymerase chain reac-
tion protocols to rule out methodological problems.
Whether the pronounced inflammatory reaction is caused
by anesthesia or the surgical preparation was not investi-
gated in the current study. On the one hand, human studies
revealed conflicting results regarding the effect of surgical
approach on systemic inflammatory reaction.19,20 On the
other hand, studies about the influence of anesthesia on in-
flammation suggest a reduction in cytokine release.21,22
Rats of both the CPB and the sham-operated groups had
a transient decrease in cognitive performance, however,
without any specific cognitive dysfunction, such as impaired
long-term or short-term memory. This unspecific cognitive
deficit lasted just until postoperative day 6. In addition, be-
havioral dimensions did not show any distinctive feature
with respect to anxiety or motivation. Taking these results
together, anesthesia, surgical preparation, or both rather
than CPB might have caused a cognitive slowing during
the first postoperative days.
These results are in agreement with those of other studies
showing similar short- and long-term cognitive outcomes in
CPB versus sham-operated rats,23,24 as well as with some
clinical studies demonstrating that coronary artery bypass
grafting with and without CPB resulted in similar incidences
of neurocognitive dysfunction.25 However, other experimen-
tal studies with this CPB model have demonstrated short-
term cognitive deficits after CPB when compared with
sham-operated rats.8,26 One difference between those studies
and the current study is the use of themodified hole-board test
to assess neurocognitive performance. This test presents
a unique test battery that allows a comprehensive and detailedrgery c October 2009
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a sensitive testing environment, allowing for the assessment
of a variety of cognitive and behavioral parameters in only
1 test.9 Specifically, this test battery allowed a complete eval-
uation of neuropsychologic performance until postoperative
day 10 compared with a preoperatively established baseline.
In addition, behavioral aspects, such as anxiety and motiva-
tion, were determined because it is well known that these
parameters can influence cognitive function.10
However, important limitations remain. Median sternot-
omy, thoracotomy, direct cardiac cannulation, and cardiac
surgery were not performed to allow the long-term survival
of the animals. Therefore the marked inflammatory response
generated by the surgical trauma or the reinfusion of blood
from cardiotomy suction into the CPB circuit and its effect
on cerebral inflammation and cognitive outcome could not
be studiedwith this particularmodel.Other limitations include
the fact that CPB was conducted under conditions of normo-
thermia to exclude any effects of temperature on cerebral
outcome. Also, young healthy rats, as used for this study,
naturally lack any of the comorbidities and significant athero-
matous disease found in the aging patient population present-
ing for cardiac surgery. Lastly, these adolescent animalsmight
be able to better compensate for at least minor postoperative
cognitive dysfunction and recover quicker and easier
compared with typical cardiac patients. Based on the current
model and results,we cannot identify the final cause of inflam-
matory activation, cognitive slowing, or both. Because we did
not include a group receiving anesthesia without undergoing
an operation, we cannot discriminate the effect of preparation
or anesthesia on inflammatory response, cognitive outcome,
or both. However, the aim of this study was to investigate
the additional influence of CPB on cerebral inflammation
and not the origin of inflammatory activation.
In summary, in this animal study increased cerebral TNF-
a expression during the early postoperative period after CPB
and the sham operation was accompanied by transient neu-
rocognitive impairment without any difference between
the groups. These results suggest that CPB alone in the ab-
sence of any other potential risk factors (embolism, aortic
manipulation, or comorbidities) does not lead to a pro-
nounced cerebral TNF-a expression or longer-lasting neuro-
cognitive deficits after cardiac surgery.
We thank Yvonne Pitz, DVM (Resident, Klinik fu¨r Anaesthesio-
logie, Klinikum rechts der Isar, Munich, Germany), for the neuro-
cognitive testing of the animals.
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